Sebastian Torke
Berlin, BE 13125, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Non-Temperature-Induced Antitumor Effects of Amplitude-Modulated Radiofrequency: Molecular and Functional Synergies with Radiotherapy.
Journal: Cancers
Published: April 09, 2026
Targeting Bruton's Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges.
Journal: Drug design, development and therapy
Published: February 25, 2026
Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B Cells.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: November 25, 2025
TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy.
Journal: Signal transduction and targeted therapy
Published: October 22, 2024
MACC1 revisited - an in-depth review of a master of metastasis.
Journal: Biomarker research
Published: August 30, 2024
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair.
Journal: Acta neuropathologica
Published: January 19, 2024
Proinflammatory CD20+ T cells contribute to CNS-directed autoimmunity.
Journal: Science translational medicine
Published: March 30, 2022
B cells reappear less mature and more activated after their anti-CD20-mediated depletion in multiple sclerosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 01, 2020
Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis.
Journal: Expert opinion on investigational drugs
Published: August 11, 2020
Last Updated: 09/26/2026